The European Commission has been at the forefront of supporting research and innovation and coordinating European and global research efforts, including preparedness for pandemics.
So far €4.1 billion has been invested from 2007 to 2019 through the 7th Framework Programme and Horizon 2020 in infectious diseases research. In addition to a number of past, and ongoing, research actions related to coronaviruses and outbreaks, the Commission also launched several special actions in 2020, as part of a €1 billion pledge for coronavirus research. These actions address epidemiology, preparedness and response to outbreaks, the development of diagnostics, treatments and vaccines, as well as the infrastructures and resources that enable this research. Horizon Europe the EU research & innovation framework programme for 2021-2027 will continue to invest in research and innovation to tackle infectious diseases including poverty-related and neglected diseases.
The Commission and national ministries have also agreed on the first ERAvsCorona action plan which lays out 10 priority short-term coordinated actions to tackle coronavirus. The action plan is already delivering results.